Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cheal

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Bioconjugate Chemistry|November 5, 2013
(18)F-labeled-bioorthogonal liposomes for in vivo targetingFabien Emmetiere, Christopher Irwin, Nerissa Therese Viola-Villegas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2014
Annotating STEAP1 regulation in prostate cancer with 89Zr immuno-PETMichael G Doran, Philip A Watson, Sarah M Cheal, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|November 10, 2012
Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventionsMichelle S Bradbury, Evan Phillips, Pablo H Montero, et al.
Molecular Pharmaceutics|November 14, 2013
Evaluation of glycodendron and synthetically modified dextran clearing agents for multistep targeting of radioisotopes for molecular imaging and radioimmunotherapySarah M Cheal, Barney Yoo, Sarah Boughdad, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 2017
Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal CancerSarah M Cheal, Edward K Fung, Mitesh Patel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 14, 2012
Imaging tumor burden in the brain with 89Zr-transferrinMichael J Evans, Jason P Holland, Samuel L Rice, et al.
Bioconjugate Chemistry|January 1, 2020
An <i>N</i>-Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted RadioimmunotherapySarah M Cheal, Mitesh Patel, Guangbin Yang, et al.
Bioconjugate Chemistry|January 25, 2021
Correction to An <i>N</i>-Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted RadioimmunotherapySarah M Cheal, Mitesh Patel, Guangbin Yang, et al.
Chemistry of Materials : a Publication of the American Chemical Society|November 14, 2017
Cancer-Targeting Ultrasmall Silica Nanoparticles for Clinical Translation: Physicochemical Structure and Biological Property CorrelationsFeng Chen, Kai Ma, Miriam Benezra, et al.
Theranostics|November 16, 2018
Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinomaSarah M Cheal, Hong Xu, Hong-Fen Guo, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Bioconjugate Chemistry|November 5, 2013
(18)F-labeled-bioorthogonal liposomes for in vivo targetingFabien Emmetiere, Christopher Irwin, Nerissa Therese Viola-Villegas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2014
Annotating STEAP1 regulation in prostate cancer with 89Zr immuno-PETMichael G Doran, Philip A Watson, Sarah M Cheal, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|November 10, 2012
Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventionsMichelle S Bradbury, Evan Phillips, Pablo H Montero, et al.
Molecular Pharmaceutics|November 14, 2013
Evaluation of glycodendron and synthetically modified dextran clearing agents for multistep targeting of radioisotopes for molecular imaging and radioimmunotherapySarah M Cheal, Barney Yoo, Sarah Boughdad, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 2017
Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal CancerSarah M Cheal, Edward K Fung, Mitesh Patel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 14, 2012
Imaging tumor burden in the brain with 89Zr-transferrinMichael J Evans, Jason P Holland, Samuel L Rice, et al.
Bioconjugate Chemistry|January 1, 2020
An <i>N</i>-Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted RadioimmunotherapySarah M Cheal, Mitesh Patel, Guangbin Yang, et al.
Bioconjugate Chemistry|January 25, 2021
Correction to An <i>N</i>-Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted RadioimmunotherapySarah M Cheal, Mitesh Patel, Guangbin Yang, et al.
Chemistry of Materials : a Publication of the American Chemical Society|November 14, 2017
Cancer-Targeting Ultrasmall Silica Nanoparticles for Clinical Translation: Physicochemical Structure and Biological Property CorrelationsFeng Chen, Kai Ma, Miriam Benezra, et al.
Theranostics|November 16, 2018
Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinomaSarah M Cheal, Hong Xu, Hong-Fen Guo, et al.
Pageof 8